Emergent Biosolutions Inc (EBS)

Operating Income

-$125.10M

Quarterly · Period ending: · USD

EBS logo

EBS Operating Income

Latest reported-$125.10M
EBS Quarterly Operating Income (-$65.10M → -$125.10M)
High-resolution chart · PNG

EBS operating income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Operating Income — Quarterly (USD)
Period endingOperating Income (USD)
-125,100,000
10,500,000
-16,600,000
76,800,000
500,000
48,600,000
-9,500,000
64,500,000
-203,500,000
39,800,000
-43,800,000
-242,100,000
-292,900,000
-147,600,000
-55,300,000
-45,300,000
-75,800,000
6,400,000
277,400,000
-34,700,000
14,500,000
95,400,000
258,100,000
61,300,000
126,000,000
-11,600,000
77,700,000
70,700,000
-7,000,000
-27,200,000
11,200,000
21,300,000
66,800,000
-9,500,000
53,092,000
47,769,000
8,529,000
14,910,000
50,929,000
35,478,000
-2,041,999
21,157,000
65,146,000
63,159,000
41,519,000
-28,310,000
44,620,000
31,032,000
7,862,000
-25,458,000
23,293,000
18,147,000
14,712,000
-13,350,000
21,030,000
9,817,000
8,653,000
-12,538,000
45,990,000
1,408,000
20,207,000
-35,506,000
34,963,000
20,605,000
14,811,000
3,178,000
4,125,000
-3,951,000
22,710,000
17,266,000
854,000
15,338,000
2,558,000
11,175,000
43,158,000
4,422,000
-8,657,000
-5,831,000
43,899,000
-1,957,000
21,948,000
21,948,000
-38,989,000
28,967,000
28,967,000
28,967,000
-49,669,000
20,874,000
20,874,000
20,874,000
-65,100,000
-34,700,000
-292,900,000
6,400,000
-65,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.